One year on : an updated systematic review of SARS-CoV-2, COVID-19 and audio-vestibular symptoms
OBJECTIVE: The aim was to systematically review the literature to December 2020, in order to provide a timely summary of evidence on SARS-CoV-2, COVID-19 and audio-vestibular symptoms.
DESIGN: The protocol was registered in the International Prospective Register of Systematic Reviews. The methods were developed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. Risk of bias was assessed using the National Institutes of Heath quality assessment tools.
STUDY SAMPLE: After rejecting 850 records, 28 case reports/series and 28 cross-sectional studies met the inclusion criteria.
RESULTS: There are multiple reports of hearing loss (e.g. sudden sensorineural), tinnitus and rotatory vertigo in adults having a wide range of COVID-19 symptom severity. The pooled estimate of prevalence based primarily on retrospective recall of symptoms, was 7.6% (CI: 2.5-15.1), 14.8% (CI: 6.3-26.1) and 7.2% (CI: 0.01-26.4), for hearing loss, tinnitus and rotatory vertigo, respectively. However, these could be an over-estimate because it was not always clear that studies report a change in symptom.
CONCLUSION: There are multiple reports of audio-vestibular symptoms associated with COVID-19. However, there is a dearth of high-quality studies comparing COVID-19 cases and controls.
REVIEW REGISTRATION: Prospective Register of Systematic Reviews (PROSPERO); registration number CRD42020227038).
Errataetall: |
CommentIn: Otol Neurotol. 2022 Feb 1;43(2):170-173. - PMID 34889826 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:60 |
---|---|
Enthalten in: |
International journal of audiology - 60(2021), 12 vom: 01. Dez., Seite 935-945 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Almufarrij, Ibrahim [VerfasserIn] |
---|
Links: |
---|
Themen: |
Coronavirus |
---|
Anmerkungen: |
Date Completed 17.11.2021 Date Revised 31.05.2022 published: Print-Electronic CommentIn: Otol Neurotol. 2022 Feb 1;43(2):170-173. - PMID 34889826 Citation Status MEDLINE |
---|
doi: |
10.1080/14992027.2021.1896793 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM323066038 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM323066038 | ||
003 | DE-627 | ||
005 | 20231225183352.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/14992027.2021.1896793 |2 doi | |
028 | 5 | 2 | |a pubmed24n1076.xml |
035 | |a (DE-627)NLM323066038 | ||
035 | |a (NLM)33750252 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Almufarrij, Ibrahim |e verfasserin |4 aut | |
245 | 1 | 0 | |a One year on |b an updated systematic review of SARS-CoV-2, COVID-19 and audio-vestibular symptoms |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 17.11.2021 | ||
500 | |a Date Revised 31.05.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a CommentIn: Otol Neurotol. 2022 Feb 1;43(2):170-173. - PMID 34889826 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a OBJECTIVE: The aim was to systematically review the literature to December 2020, in order to provide a timely summary of evidence on SARS-CoV-2, COVID-19 and audio-vestibular symptoms | ||
520 | |a DESIGN: The protocol was registered in the International Prospective Register of Systematic Reviews. The methods were developed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. Risk of bias was assessed using the National Institutes of Heath quality assessment tools | ||
520 | |a STUDY SAMPLE: After rejecting 850 records, 28 case reports/series and 28 cross-sectional studies met the inclusion criteria | ||
520 | |a RESULTS: There are multiple reports of hearing loss (e.g. sudden sensorineural), tinnitus and rotatory vertigo in adults having a wide range of COVID-19 symptom severity. The pooled estimate of prevalence based primarily on retrospective recall of symptoms, was 7.6% (CI: 2.5-15.1), 14.8% (CI: 6.3-26.1) and 7.2% (CI: 0.01-26.4), for hearing loss, tinnitus and rotatory vertigo, respectively. However, these could be an over-estimate because it was not always clear that studies report a change in symptom | ||
520 | |a CONCLUSION: There are multiple reports of audio-vestibular symptoms associated with COVID-19. However, there is a dearth of high-quality studies comparing COVID-19 cases and controls | ||
520 | |a REVIEW REGISTRATION: Prospective Register of Systematic Reviews (PROSPERO); registration number CRD42020227038) | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Systematic Review | |
650 | 4 | |a Coronavirus | |
650 | 4 | |a Covid-19 | |
650 | 4 | |a SARS-CoV-2 | |
650 | 4 | |a hearing loss | |
650 | 4 | |a tinnitus | |
650 | 4 | |a vertigo | |
700 | 1 | |a Munro, Kevin J |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t International journal of audiology |d 2002 |g 60(2021), 12 vom: 01. Dez., Seite 935-945 |w (DE-627)NLM119085674 |x 1708-8186 |7 nnns |
773 | 1 | 8 | |g volume:60 |g year:2021 |g number:12 |g day:01 |g month:12 |g pages:935-945 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/14992027.2021.1896793 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 60 |j 2021 |e 12 |b 01 |c 12 |h 935-945 |